About the Choroidal Melanoma Session
Choroidal melanoma, a rare form of eye cancer, arises from the pigment-producing cells in the choroid layer of the eye. Despite its rarity, it poses a significant threat to vision and can metastasize, primarily to the liver, if left untreated. Research in this area focuses on early detection methods, such as high-resolution imaging techniques and genetic profiling, to identify at-risk individuals and provide timely interventions. Treatment options include radiation therapy, surgery, and in some cases, enucleation (removal of the eye). The development of targeted therapies and immunotherapies holds promise for improving outcomes and reducing the risk of metastasis in choroidal melanoma patients. Ongoing efforts in cancer research aim to elucidate the molecular mechanisms driving this disease and discover novel therapeutic targets to enhance patient care.
Topics Covered in Choroidal Melanoma
Nevus vs Melanoma
Ocular Ultrasound
Plaque & Proton Therapy
Enucleation
Gene Expression Profiling
Liver Surveillance
Related Scientific Sessions at CIOC 2027
Why Attend the Choroidal Melanoma Conference 2027
Earn CPD Credit
Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.
Present Your Research
Oral and poster slots for original Choroidal Melanoma work, reviewed by the scientific committee.
Network Globally
Meet oncologists, cancer researchers, and clinical specialists from around the world across three days.
Publish & Get Indexed
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Learn from Keynotes
Plenary lectures from leading voices shaping Choroidal Melanoma research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join CIOC 2027 for the Choroidal Melanoma track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
Choroidal Melanoma Conference 2027 — FAQs
What is the Choroidal Melanoma track at CIOC 2027?
The Choroidal Melanoma track is a dedicated stream within CIOC 2027 covering the latest research, clinical innovation, and best practice in Choroidal Melanoma. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Choroidal Melanoma sessions?
Cancer researchers and clinicians, educators and students with an interest in Choroidal Melanoma are all welcome — whether presenting or attending.
Can I present my research in the Choroidal Melanoma track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Choroidal Melanoma sessions?
Yes. CIOC 2027 is a hybrid conference — attend the Choroidal Melanoma track in person in Singapore or join live online, with on-demand access afterward.
Join the CIOC 2027 delegation
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.
